Group One Trading
AVNR

Group One Trading’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Group One Trading’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-662,100
Closed -$11.2M – 5696
2014
Q4 		$11.2M Buy
662,100
+94,800
+17% +$1.33M 0.17% 108
2014
Q3 		$6.76M Buy
567,300
+314,600
+124% +$2.15M 0.1% 206
2014
Q2 		$1.43M Buy
252,700
+44,900
+22% +$207K 0.02% 912
2014
Q1 		$763K Sell
207,800
-194,200
-48% -$740K 0.01% 1300
2013
Q4 		$1.35M Buy
402,000
+144,100
+56% +$595K 0.02% 905
2013
Q3 		$1.09M Buy
257,900
+242,800
+1,608% +$1.15M 0.02% 946
2013
Q2 		$69K Buy
+15,100
New +$51.9K ﹤0.01% 3152

Group One Trading's AVNR Position: Q1 2015 in Review

Group One Trading sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,607 shares — an estimated $27K sold.

Group One Trading first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $4.73M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Group One Trading reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Group One Trading sold 1,607 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $27K.
  • Group One Trading first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
  • Group One Trading's AVANIR PHARMACEUTICALS, INC CL A position peaked at $4.73M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.